Stock screenerAll disclosures →
EDGAR →
IVVD
Conviction 20HealthcareScan · Mon, Aug 10, 2026IVVD$0.6731-9.04%
ResistanceSupportVol 14Vol MA14 4.63M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.6731
Change-9.04%
Gap+0.66%
Rel volume6.35×
Avg volume3.94M
Avg $ vol2.55M
SMA 200.6510
SMA 500.8203
SMA 2001.59
Price vs 50-17.94%
Price vs 200-57.65%
MA stackbearish
50/200 cross—
Supertrenddown · 0.7495
RSI (14)47
MACD hist0.02
MACD crossbull · 3d
Stoch %K / %D66 / 72
ADX (14)27
+DI / −DI21 / 19
RSI divergence—
MACD divergence—
ATR %+10.07%
ADR %8.84%
52w high2.88
52w low0.5201
From 52w high-76.63%
Above 52w low+29.42%
New 52w highNo
SqueezeOff
Bollinger width52.32%
%B0.56
Donchian pos49.34%
Donchian high0.8224
Donchian low0.5277
AVWAP (52w high)1.59
vs AVWAP high-57.62%
AVWAP (52w low)1.55
vs AVWAP low-56.70%
OBV trendDown
Chaikin MF (20)-0.38
Today vs 20d6.35×
Avg vol (14d)4.63M
Avg vol (20d)3.94M
Avg $ vol (20d)2.55M
Market cap198.3M
RS 3m (vs SPY)-53.95%
RS 6m (vs SPY)-70.84%
RS line new highNo
Trend template0/8
Technical rank10.7
1 week+22.03%
1 month-14.08%
3 months-55.13%
6 months-57.67%
1 year-10.68%
YTD-73.08%
P/E-3.78
P/B0.98
P/S3.71
P/FCF-3.40
EPS-0.3000
Div yield—
ROE-25.85%
ROA-21.71%
Debt/Eq—
Current6.47
EV/EBITDA—
Gross margin—
Net margin-98.25%
Rev growth110.47%
EPS growth69.11%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value14.15M
Revenue13.74M
Net income-41.4M
Gross profit—
Free cash flow-58.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out294.61M
Employees122
ListedFri, Aug 6, 2021
Free float155.54M
Float %66.7%
Short interest29.31M
Days to cover8.6d
Short volume63.4%
Squeeze score93 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank10.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.01
Support0.5658
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IVVD
No recent disclosed trades by Congress in IVVD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IVVD · 7 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BOLNO PAUL Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 32.88K | $0 | 2026-05-19 | 2026-05-21 |
MCGUIRE TERRANCE Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Royan Ajay Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Berry Tamsin Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
M28 Capital Management LP Insider · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Elia Marc Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
MCLAUGHLIN KEVIN F Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in IVVD · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.